#METABOLOMICS WORKBENCH xia_lab_20230726_140432 DATATRACK_ID:4187 STUDY_ID:ST002798 ANALYSIS_ID:AN004552
VERSION                          	1
CREATED_ON                       	07-27-2023
#PROJECT
PR:PROJECT_TITLE                 	MetaboAnalystR 4.0: towards a unified LC-MS workflow for global metabolomics
PR:PROJECT_TYPE                  	MS/MS qualification and MS quantification study
PR:PROJECT_SUMMARY               	Here we introduce MetaboAnalystR 4.0, an open-source R package that have been
PR:PROJECT_SUMMARY               	developed to provide a unified workflow to help address three key bioinformatics
PR:PROJECT_SUMMARY               	bottlenecks facing LC-MS-based global metabolomics, including: 1) auto-optimized
PR:PROJECT_SUMMARY               	LC-MS spectral processing for feature detection and quantification; 2)
PR:PROJECT_SUMMARY               	streamlined MS/MS spectral deconvolution and compound annotation coupled with
PR:PROJECT_SUMMARY               	comprehensive spectral reference databases (~1.5 million MS2 spectra); 3) a
PR:PROJECT_SUMMARY               	sensitive functional interpretation module for functional analysis directly from
PR:PROJECT_SUMMARY               	LC-MS and MS/MS results. During our validation case studies in comparison with
PR:PROJECT_SUMMARY               	other well-established approaches, MetaboAnalystR 4.0 has identified > 10%
PR:PROJECT_SUMMARY               	more high-quality MS and MS/MS features; it has also significantly increased
PR:PROJECT_SUMMARY               	true positive rate of identification (> 40%) without increasing false
PR:PROJECT_SUMMARY               	positives using both data-dependent acquisition (DDA) and data-independent
PR:PROJECT_SUMMARY               	acquisition (DIA) datasets; finally, pathway enrichment analysis integrating
PR:PROJECT_SUMMARY               	LC-MS and MS/MS spectra from COVID-19 datasets has produced results that are
PR:PROJECT_SUMMARY               	better aligned with literature report.
PR:INSTITUTE                     	McGill University
PR:DEPARTMENT                    	Faculty of Agricultural and Environmental Sciences
PR:LABORATORY                    	Xia Lab, Institute of Parasitology
PR:LAST_NAME                     	Xia
PR:FIRST_NAME                    	Jeff
PR:ADDRESS                       	Macdonald Campus, McGill University 21,111 Lakeshore Road
PR:EMAIL                         	jeff.xia@mcgill.ca
PR:PHONE                         	5146605018
PR:FUNDING_SOURCE                	NIH, TIMIC, Genome Canada, Génome Québec
PR:DOI                           	http://dx.doi.org/10.21228/M88Q6W
PR:CONTRIBUTORS                  	Zhiqiang Pang, Lei Xu, Charles Viau
#STUDY
ST:STUDY_TITLE                   	Evaluation of quantitative performance with serial dilutions
ST:STUDY_TYPE                    	Untargeted Metabolomics
ST:STUDY_SUMMARY                 	To benchmark the quantitative performance of MetaboAnalystR, a dilution series
ST:STUDY_SUMMARY                 	was prepared by mixing serum and urine in a cross-gradient manner (0:100,
ST:STUDY_SUMMARY                 	1:1024, 1:256, 1:64, 1:16, 1:4, 1:1, 4:1, 16:1, 64:1, 256:1, 1024:1, 100:0).
ST:INSTITUTE                     	McGill University
ST:DEPARTMENT                    	Faculty of Agricultural and Environmental Sciences
ST:LABORATORY                    	Xia Lab, Institute of Parasitology
ST:LAST_NAME                     	Xia
ST:FIRST_NAME                    	Jeff
ST:ADDRESS                       	Macdonald Campus, McGill University 21,111 Lakeshore Road
ST:EMAIL                         	jeff.xia@mcgill.ca
ST:PHONE                         	5143988668
ST:SUBMIT_DATE                   	2023-07-26
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
SU:AGE_OR_AGE_RANGE              	22-32
SU:GENDER                        	Male
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	SA_01_C18neg	SA_01_C18neg	Mode:C18 Negative | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SA_02_C18neg	SA_02_C18neg	Mode:C18 Negative | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SA_03_C18neg	SA_03_C18neg	Mode:C18 Negative | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SM_01_C18neg	SM_01_C18neg	Mode:C18 Negative | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SM_02_C18neg	SM_02_C18neg	Mode:C18 Negative | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SM_03_C18neg	SM_03_C18neg	Mode:C18 Negative | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SL_01_C18neg	SL_01_C18neg	Mode:C18 Negative | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SL_02_C18neg	SL_02_C18neg	Mode:C18 Negative | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SL_03_C18neg	SL_03_C18neg	Mode:C18 Negative | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_DIA_01_NEGATIVE_RPLC	20220406_URINE_DIA_01_NEGATIVE_RPLC	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20220406_URINE_DIA_01_NEGATIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_DIA_02_NEGATIVE_RPLC	20220406_URINE_DIA_02_NEGATIVE_RPLC	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20220406_URINE_DIA_02_NEGATIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN01_NEGATIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN01_NEGATIVE_RPLC	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN01_NEGATIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN02_NEGATIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN02_NEGATIVE_RPLC	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN02_NEGATIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN03_NEGATIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN03_NEGATIVE_RPLC	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN03_NEGATIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN04_NEGATIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN04_NEGATIVE_RPLC	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN04_NEGATIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN05_NEGATIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN05_NEGATIVE_RPLC	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN05_NEGATIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN06_NEGATIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN06_NEGATIVE_RPLC	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN06_NEGATIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	SG_01_C18neg	SG_01_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SG_02_C18neg	SG_02_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SG_03_C18neg	SG_03_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA1_1_C18neg	URINEDDA1_1_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA1_1_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA1_C18neg	URINEDDA1_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA1_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA2_1_C18neg	URINEDDA2_1_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA2_1_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA2_C18neg	URINEDDA2_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA2_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA3_1_C18neg	URINEDDA3_1_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA3_1_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA3_C18neg	URINEDDA3_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA3_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA1_1_C18neg	URINEDIA1_1_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA1_1_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA1_C18neg	URINEDIA1_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA1_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA2_1_C18neg	URINEDIA2_1_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA2_1_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA2_C18neg	URINEDIA2_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA2_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA3_1_C18neg	URINEDIA3_1_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA3_1_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA3_C18neg	URINEDIA3_C18neg	Mode:C18 Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA3_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SB_01_C18neg	SB_01_C18neg	Mode:C18 Negative | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SB_02_C18neg	SB_02_C18neg	Mode:C18 Negative | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SB_03_C18neg	SB_03_C18neg	Mode:C18 Negative | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SE_01_C18neg	SE_01_C18neg	Mode:C18 Negative | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SE_02_C18neg	SE_02_C18neg	Mode:C18 Negative | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SE_03_C18neg	SE_03_C18neg	Mode:C18 Negative | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SC_01_C18neg	SC_01_C18neg	Mode:C18 Negative | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SC_02_C18neg	SC_02_C18neg	Mode:C18 Negative | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SC_03_C18neg	SC_03_C18neg	Mode:C18 Negative | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SF_01_C18neg	SF_01_C18neg	Mode:C18 Negative | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SF_02_C18neg	SF_02_C18neg	Mode:C18 Negative | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SF_03_C18neg	SF_03_C18neg	Mode:C18 Negative | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SI_01_C18neg	SI_01_C18neg	Mode:C18 Negative | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SI_02_C18neg	SI_02_C18neg	Mode:C18 Negative | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SI_03_C18neg	SI_03_C18neg	Mode:C18 Negative | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SD_01_C18neg	SD_01_C18neg	Mode:C18 Negative | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SD_02_C18neg	SD_02_C18neg	Mode:C18 Negative | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SD_03_C18neg	SD_03_C18neg	Mode:C18 Negative | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SK_01_C18neg	SK_01_C18neg	Mode:C18 Negative | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SK_02_C18neg	SK_02_C18neg	Mode:C18 Negative | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SK_03_C18neg	SK_03_C18neg	Mode:C18 Negative | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SH_01_C18neg	SH_01_C18neg	Mode:C18 Negative | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SH_02_C18neg	SH_02_C18neg	Mode:C18 Negative | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SH_03_C18neg	SH_03_C18neg	Mode:C18 Negative | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_01_C18neg	SJ_01_C18neg	Mode:C18 Negative | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_01_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_02_C18neg	SJ_02_C18neg	Mode:C18 Negative | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_02_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_03_C18neg	SJ_03_C18neg	Mode:C18 Negative | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_03_C18neg.mzML
SUBJECT_SAMPLE_FACTORS           	SA_01_C18pos	SA_01_C18pos	Mode:C18 Positive | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SA_02_C18pos	SA_02_C18pos	Mode:C18 Positive | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SA_03_C18pos	SA_03_C18pos	Mode:C18 Positive | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SM_01_C18pos	SM_01_C18pos	Mode:C18 Positive | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SM_02_C18pos	SM_02_C18pos	Mode:C18 Positive | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SM_03_C18pos	SM_03_C18pos	Mode:C18 Positive | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SL_01_C18pos	SL_01_C18pos	Mode:C18 Positive | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SL_02_C18pos	SL_02_C18pos	Mode:C18 Positive | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SL_03_C18pos	SL_03_C18pos	Mode:C18 Positive | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_DIA_01_POSITIVE_RPLC	20220406_URINE_DIA_01_POSITIVE_RPLC	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20220406_URINE_DIA_01_POSITIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_DIA_02_POSITIVE_RPLC	20220406_URINE_DIA_02_POSITIVE_RPLC	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20220406_URINE_DIA_02_POSITIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN01_POSITIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN01_POSITIVE_RPLC	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN01_POSITIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN02_POSITIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN02_POSITIVE_RPLC	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN02_POSITIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN03_POSITIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN03_POSITIVE_RPLC	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN03_POSITIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN04_POSITIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN04_POSITIVE_RPLC	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN04_POSITIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN05_POSITIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN05_POSITIVE_RPLC	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN05_POSITIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	20220406_URINE_NonTargetDDMS2_SCAN06_POSITIVE_RPLC	20220406_URINE_NonTargetDDMS2_SCAN06_POSITIVE_RPLC	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220406_URINE_NonTargetDDMS2_SCAN06_POSITIVE_RPLC.mzML
SUBJECT_SAMPLE_FACTORS           	SG_01_C18pos	SG_01_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SG_02_C18pos	SG_02_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SG_03_C18pos	SG_03_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA1_1_C18pos	URINEDDA1_1_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA1_1_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA1_C18pos	URINEDDA1_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA1_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA2_1_C18pos	URINEDDA2_1_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA2_1_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA2_C18pos	URINEDDA2_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA2_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA3_1_C18pos	URINEDDA3_1_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA3_1_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDDA3_C18pos	URINEDDA3_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=URINEDDA3_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA1_1_C18pos	URINEDIA1_1_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA1_1_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA1_C18pos	URINEDIA1_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA1_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA2_1_C18pos	URINEDIA2_1_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA2_1_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA2_C18pos	URINEDIA2_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA2_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA3_1_C18pos	URINEDIA3_1_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA3_1_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	URINEDIA3_C18pos	URINEDIA3_C18pos	Mode:C18 Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=URINEDIA3_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SB_01_C18pos	SB_01_C18pos	Mode:C18 Positive | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SB_02_C18pos	SB_02_C18pos	Mode:C18 Positive | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SB_03_C18pos	SB_03_C18pos	Mode:C18 Positive | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SE_01_C18pos	SE_01_C18pos	Mode:C18 Positive | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SE_02_C18pos	SE_02_C18pos	Mode:C18 Positive | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SE_03_C18pos	SE_03_C18pos	Mode:C18 Positive | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SC_01_C18pos	SC_01_C18pos	Mode:C18 Positive | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SC_02_C18pos	SC_02_C18pos	Mode:C18 Positive | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SC_03_C18pos	SC_03_C18pos	Mode:C18 Positive | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SF_01_C18pos	SF_01_C18pos	Mode:C18 Positive | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SF_02_C18pos	SF_02_C18pos	Mode:C18 Positive | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SF_03_C18pos	SF_03_C18pos	Mode:C18 Positive | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SI_01_C18pos	SI_01_C18pos	Mode:C18 Positive | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SI_02_C18pos	SI_02_C18pos	Mode:C18 Positive | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SI_03_C18pos	SI_03_C18pos	Mode:C18 Positive | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SD_01_C18pos	SD_01_C18pos	Mode:C18 Positive | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SD_02_C18pos	SD_02_C18pos	Mode:C18 Positive | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SD_03_C18pos	SD_03_C18pos	Mode:C18 Positive | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SK_01_C18pos	SK_01_C18pos	Mode:C18 Positive | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SK_02_C18pos	SK_02_C18pos	Mode:C18 Positive | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SK_03_C18pos	SK_03_C18pos	Mode:C18 Positive | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SH_01_C18pos	SH_01_C18pos	Mode:C18 Positive | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SH_02_C18pos	SH_02_C18pos	Mode:C18 Positive | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SH_03_C18pos	SH_03_C18pos	Mode:C18 Positive | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_01_C18pos	SJ_01_C18pos	Mode:C18 Positive | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_01_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_02_C18pos	SJ_02_C18pos	Mode:C18 Positive | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_02_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_03_C18pos	SJ_03_C18pos	Mode:C18 Positive | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_03_C18pos.mzML
SUBJECT_SAMPLE_FACTORS           	SA_01_HILICneg	SA_01_HILICneg	Mode:HILIC Negative | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SA_02_HILICneg	SA_02_HILICneg	Mode:HILIC Negative | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SA_03_HILICneg	SA_03_HILICneg	Mode:HILIC Negative | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SM_01_HILICneg	SM_01_HILICneg	Mode:HILIC Negative | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SM_02_HILICneg	SM_02_HILICneg	Mode:HILIC Negative | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SM_03_HILICneg	SM_03_HILICneg	Mode:HILIC Negative | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SL_01_HILICneg	SL_01_HILICneg	Mode:HILIC Negative | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SL_02_HILICneg	SL_02_HILICneg	Mode:HILIC Negative | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SL_03_HILICneg	SL_03_HILICneg	Mode:HILIC Negative | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	20210908urineHILICDDMS_HILICneg	20210908urineHILICDDMS_HILICneg	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20210908urineHILICDDMS_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	20210908urineHILICDIA1_HILICneg	20210908urineHILICDIA1_HILICneg	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20210908urineHILICDIA1_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	20210908urineHILICDIA2_HILICneg	20210908urineHILICDIA2_HILICneg	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20210908urineHILICDIA2_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	20210908urineHILICDIA3_HILICneg	20210908urineHILICDIA3_HILICneg	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20210908urineHILICDIA3_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	20220413_URINE_HILIC_DIA01_NEGATIVE	20220413_URINE_HILIC_DIA01_NEGATIVE	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20220413_URINE_HILIC_DIA01_NEGATIVE.mzML
SUBJECT_SAMPLE_FACTORS           	20220413_URINE_HILIC_DIA02_NEGATIVE	20220413_URINE_HILIC_DIA02_NEGATIVE	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20220413_URINE_HILIC_DIA02_NEGATIVE.mzML
SUBJECT_SAMPLE_FACTORS           	20220413_URINE_HILIC_NonTargetedDDMS_SCAN01_NEGATIVE	20220413_URINE_HILIC_NonTargetedDDMS_SCAN01_NEGATIVE	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220413_URINE_HILIC_NonTargetedDDMS_SCAN01_NEGATIVE.mzML
SUBJECT_SAMPLE_FACTORS           	20220413_URINE_HILIC_NonTargetedDDMS_SCAN02_NEGATIVE	20220413_URINE_HILIC_NonTargetedDDMS_SCAN02_NEGATIVE	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220413_URINE_HILIC_NonTargetedDDMS_SCAN02_NEGATIVE.mzML
SUBJECT_SAMPLE_FACTORS           	20220413_URINE_HILIC_NonTargetedDDMS_SCAN03_NEGATIVE	20220413_URINE_HILIC_NonTargetedDDMS_SCAN03_NEGATIVE	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220413_URINE_HILIC_NonTargetedDDMS_SCAN03_NEGATIVE.mzML
SUBJECT_SAMPLE_FACTORS           	20220413_URINE_HILIC_NonTargetedDDMS_SCAN04_NEGATIVE	20220413_URINE_HILIC_NonTargetedDDMS_SCAN04_NEGATIVE	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220413_URINE_HILIC_NonTargetedDDMS_SCAN04_NEGATIVE.mzML
SUBJECT_SAMPLE_FACTORS           	20220413_URINE_HILIC_NonTargetedDDMS_SCAN05_NEGATIVE	20220413_URINE_HILIC_NonTargetedDDMS_SCAN05_NEGATIVE	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220413_URINE_HILIC_NonTargetedDDMS_SCAN05_NEGATIVE.mzML
SUBJECT_SAMPLE_FACTORS           	20220413_URINE_HILIC_NonTargetedDDMS_SCAN06_NEGATIVE	20220413_URINE_HILIC_NonTargetedDDMS_SCAN06_NEGATIVE	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220413_URINE_HILIC_NonTargetedDDMS_SCAN06_NEGATIVE.mzML
SUBJECT_SAMPLE_FACTORS           	SG_01_HILICneg	SG_01_HILICneg	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SG_02_HILICneg	SG_02_HILICneg	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SG_03_HILICneg	SG_03_HILICneg	Mode:HILIC Negative | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SB_01_HILICneg	SB_01_HILICneg	Mode:HILIC Negative | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SB_02_HILICneg	SB_02_HILICneg	Mode:HILIC Negative | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SB_03_HILICneg	SB_03_HILICneg	Mode:HILIC Negative | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SE_01_HILICneg	SE_01_HILICneg	Mode:HILIC Negative | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SE_02_HILICneg	SE_02_HILICneg	Mode:HILIC Negative | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SE_03_HILICneg	SE_03_HILICneg	Mode:HILIC Negative | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SC_01_HILICneg	SC_01_HILICneg	Mode:HILIC Negative | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SC_02_HILICneg	SC_02_HILICneg	Mode:HILIC Negative | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SC_03_HILICneg	SC_03_HILICneg	Mode:HILIC Negative | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SF_01_HILICneg	SF_01_HILICneg	Mode:HILIC Negative | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SF_02_HILICneg	SF_02_HILICneg	Mode:HILIC Negative | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SF_03_HILICneg	SF_03_HILICneg	Mode:HILIC Negative | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SI_01_HILICneg	SI_01_HILICneg	Mode:HILIC Negative | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SI_02_HILICneg	SI_02_HILICneg	Mode:HILIC Negative | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SI_03_HILICneg	SI_03_HILICneg	Mode:HILIC Negative | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SD_01_HILICneg	SD_01_HILICneg	Mode:HILIC Negative | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SD_02_HILICneg	SD_02_HILICneg	Mode:HILIC Negative | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SD_03_HILICneg	SD_03_HILICneg	Mode:HILIC Negative | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SK_01_HILICneg	SK_01_HILICneg	Mode:HILIC Negative | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SK_02_HILICneg	SK_02_HILICneg	Mode:HILIC Negative | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SK_03_HILICneg	SK_03_HILICneg	Mode:HILIC Negative | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SH_01_HILICneg	SH_01_HILICneg	Mode:HILIC Negative | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SH_02_HILICneg	SH_02_HILICneg	Mode:HILIC Negative | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SH_03_HILICneg	SH_03_HILICneg	Mode:HILIC Negative | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_01_HILICneg	SJ_01_HILICneg	Mode:HILIC Negative | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_01_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_02_HILICneg	SJ_02_HILICneg	Mode:HILIC Negative | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_02_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_03_HILICneg	SJ_03_HILICneg	Mode:HILIC Negative | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_03_HILICneg.mzML
SUBJECT_SAMPLE_FACTORS           	SA_01_HILICpos	SA_01_HILICpos	Mode:HILIC Positive | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SA_02_HILICpos	SA_02_HILICpos	Mode:HILIC Positive | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SA_03_HILICpos	SA_03_HILICpos	Mode:HILIC Positive | Ratio:0;100	MS_mode=MS1; RAW_FILE_NAME=SA_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SM_01_HILICpos	SM_01_HILICpos	Mode:HILIC Positive | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SM_02_HILICpos	SM_02_HILICpos	Mode:HILIC Positive | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SM_03_HILICpos	SM_03_HILICpos	Mode:HILIC Positive | Ratio:100;0	MS_mode=MS1; RAW_FILE_NAME=SM_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SL_01_HILICpos	SL_01_HILICpos	Mode:HILIC Positive | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SL_02_HILICpos	SL_02_HILICpos	Mode:HILIC Positive | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SL_03_HILICpos	SL_03_HILICpos	Mode:HILIC Positive | Ratio:1024;1	MS_mode=MS1; RAW_FILE_NAME=SL_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	20210908urineHILICDDMS_HILICpos	20210908urineHILICDDMS_HILICpos	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20210908urineHILICDDMS_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	20210908urineHILICDIA1_HILICpos	20210908urineHILICDIA1_HILICpos	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20210908urineHILICDIA1_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	20210908urineHILICDIA2_HILICpos	20210908urineHILICDIA2_HILICpos	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20210908urineHILICDIA2_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	20210908urineHILICDIA3_HILICpos	20210908urineHILICDIA3_HILICpos	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20210908urineHILICDIA3_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	20220412_URINE_HILIC_DIA_01_POS	20220412_URINE_HILIC_DIA_01_POS	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20220412_URINE_HILIC_DIA_01_POS.mzML
SUBJECT_SAMPLE_FACTORS           	20220412_URINE_HILIC_DIA_02_POS	20220412_URINE_HILIC_DIA_02_POS	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS SWATH-DIA; RAW_FILE_NAME=20220412_URINE_HILIC_DIA_02_POS.mzML
SUBJECT_SAMPLE_FACTORS           	20220412_URINE_HILIC_NonTargetedDDMS_SCAN01_POS	20220412_URINE_HILIC_NonTargetedDDMS_SCAN01_POS	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220412_URINE_HILIC_NonTargetedDDMS_SCAN01_POS.mzML
SUBJECT_SAMPLE_FACTORS           	20220412_URINE_HILIC_NonTargetedDDMS_SCAN02_POS	20220412_URINE_HILIC_NonTargetedDDMS_SCAN02_POS	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220412_URINE_HILIC_NonTargetedDDMS_SCAN02_POS.mzML
SUBJECT_SAMPLE_FACTORS           	20220412_URINE_HILIC_NonTargetedDDMS_SCAN03_POS	20220412_URINE_HILIC_NonTargetedDDMS_SCAN03_POS	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220412_URINE_HILIC_NonTargetedDDMS_SCAN03_POS.mzML
SUBJECT_SAMPLE_FACTORS           	20220412_URINE_HILIC_NonTargetedDDMS_SCAN04_POS	20220412_URINE_HILIC_NonTargetedDDMS_SCAN04_POS	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220412_URINE_HILIC_NonTargetedDDMS_SCAN04_POS.mzML
SUBJECT_SAMPLE_FACTORS           	20220412_URINE_HILIC_NonTargetedDDMS_SCAN05_POS	20220412_URINE_HILIC_NonTargetedDDMS_SCAN05_POS	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220412_URINE_HILIC_NonTargetedDDMS_SCAN05_POS.mzML
SUBJECT_SAMPLE_FACTORS           	20220412_URINE_HILIC_NonTargetedDDMS_SCAN06_POS	20220412_URINE_HILIC_NonTargetedDDMS_SCAN06_POS	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS/MS DDA; RAW_FILE_NAME=20220412_URINE_HILIC_NonTargetedDDMS_SCAN06_POS.mzML
SUBJECT_SAMPLE_FACTORS           	SG_01_HILICpos	SG_01_HILICpos	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SG_02_HILICpos	SG_02_HILICpos	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SG_03_HILICpos	SG_03_HILICpos	Mode:HILIC Positive | Ratio:1;1	MS_mode=MS1; RAW_FILE_NAME=SG_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SB_01_HILICpos	SB_01_HILICpos	Mode:HILIC Positive | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SB_02_HILICpos	SB_02_HILICpos	Mode:HILIC Positive | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SB_03_HILICpos	SB_03_HILICpos	Mode:HILIC Positive | Ratio:1;1024	MS_mode=MS1; RAW_FILE_NAME=SB_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SE_01_HILICpos	SE_01_HILICpos	Mode:HILIC Positive | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SE_02_HILICpos	SE_02_HILICpos	Mode:HILIC Positive | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SE_03_HILICpos	SE_03_HILICpos	Mode:HILIC Positive | Ratio:1;16	MS_mode=MS1; RAW_FILE_NAME=SE_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SC_01_HILICpos	SC_01_HILICpos	Mode:HILIC Positive | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SC_02_HILICpos	SC_02_HILICpos	Mode:HILIC Positive | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SC_03_HILICpos	SC_03_HILICpos	Mode:HILIC Positive | Ratio:1;256	MS_mode=MS1; RAW_FILE_NAME=SC_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SF_01_HILICpos	SF_01_HILICpos	Mode:HILIC Positive | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SF_02_HILICpos	SF_02_HILICpos	Mode:HILIC Positive | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SF_03_HILICpos	SF_03_HILICpos	Mode:HILIC Positive | Ratio:1;4	MS_mode=MS1; RAW_FILE_NAME=SF_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SI_01_HILICpos	SI_01_HILICpos	Mode:HILIC Positive | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SI_02_HILICpos	SI_02_HILICpos	Mode:HILIC Positive | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SI_03_HILICpos	SI_03_HILICpos	Mode:HILIC Positive | Ratio:16;1	MS_mode=MS1; RAW_FILE_NAME=SI_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SD_01_HILICpos	SD_01_HILICpos	Mode:HILIC Positive | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SD_02_HILICpos	SD_02_HILICpos	Mode:HILIC Positive | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SD_03_HILICpos	SD_03_HILICpos	Mode:HILIC Positive | Ratio:1;64	MS_mode=MS1; RAW_FILE_NAME=SD_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SK_01_HILICpos	SK_01_HILICpos	Mode:HILIC Positive | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SK_02_HILICpos	SK_02_HILICpos	Mode:HILIC Positive | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SK_03_HILICpos	SK_03_HILICpos	Mode:HILIC Positive | Ratio:256;1	MS_mode=MS1; RAW_FILE_NAME=SK_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SH_01_HILICpos	SH_01_HILICpos	Mode:HILIC Positive | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SH_02_HILICpos	SH_02_HILICpos	Mode:HILIC Positive | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SH_03_HILICpos	SH_03_HILICpos	Mode:HILIC Positive | Ratio:4;1	MS_mode=MS1; RAW_FILE_NAME=SH_03_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_01_HILICpos	SJ_01_HILICpos	Mode:HILIC Positive | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_01_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_02_HILICpos	SJ_02_HILICpos	Mode:HILIC Positive | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_02_HILICpos.mzML
SUBJECT_SAMPLE_FACTORS           	SJ_03_HILICpos	SJ_03_HILICpos	Mode:HILIC Positive | Ratio:64;1	MS_mode=MS1; RAW_FILE_NAME=SJ_03_HILICpos.mzML
#COLLECTION
CO:COLLECTION_SUMMARY            	serum standards and an urine sample is mixed based on a series of dilution ratio
CO:SAMPLE_TYPE                   	Urine
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	Healthy volunteers were recruited. About 1 mL urine were collected. The urine
TR:TREATMENT_SUMMARY             	sample was mixed with a serum sample then. No other treatment applied.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	A urine sample was collected from a donor of McGill University45. A total of
SP:SAMPLEPREP_SUMMARY            	100mL urine was sub-sampled and frozen at -80°C. A human standard serum sample
SP:SAMPLEPREP_SUMMARY            	(Sigma-Aldrich, Sigma, St. Louis, MO, USA) and the urine were thawed in ice for
SP:SAMPLEPREP_SUMMARY            	1 hour, and then vortexed for 30 seconds to ensure homogeneity. A total of 13
SP:SAMPLEPREP_SUMMARY            	Eppendorf microcentrifuge tubes were prepared and labelled from A to M. For
SP:SAMPLEPREP_SUMMARY            	tubes A to E, 150 µl urine was transferred into each of them. For tube G to K,
SP:SAMPLEPREP_SUMMARY            	150 µl standard serum was transferred into each of them. 250 µl pure urine
SP:SAMPLEPREP_SUMMARY            	were transferred into tube L, and 250 µl pure serum were transferred into tube
SP:SAMPLEPREP_SUMMARY            	M. Then, 50 µl pure serum were extracted and mixed into tube E. Then, 50 µl
SP:SAMPLEPREP_SUMMARY            	liquids were extracted and mixed into tube D, and so on until tube A. Same
SP:SAMPLEPREP_SUMMARY            	operations were repeated for pure urine tube L, and tube G-K. Finally, 75 µl
SP:SAMPLEPREP_SUMMARY            	pure urine and serum were extracted respectively and mixed into tube F. At a
SP:SAMPLEPREP_SUMMARY            	result, a total of 11 dilution mixtures and 2 pure samples were generated.
SP:PROCESSING_STORAGE_CONDITIONS 	On ice
SP:EXTRACTION_METHOD             	Organic reagent
SP:EXTRACT_STORAGE               	On ice
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	For C18 columns, the composition of the mobile phases A and B were 0.1% FA in
CH:CHROMATOGRAPHY_SUMMARY        	water and 0.1% FA in ACN, respectively.
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Thermo Hypersil GOLD aQ (100 x 2.1mm,1.9um)
CH:COLUMN_TEMPERATURE            	40
CH:FLOW_GRADIENT                 	0-1min: 95%A; 1-3min:50%A; 3-15min:20%A; 15-15.5:0%A; 15.5-19.5min: 0%A;
CH:FLOW_GRADIENT                 	19.5%-20: 95%A
CH:FLOW_RATE                     	0.4 mL/min
CH:SOLVENT_A                     	100% water; 0.1% formic acid
CH:SOLVENT_B                     	100% acetonitrile; 0.1% formic acid
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:MS_COMMENTS                   	For the C18 column, an electrospray ion (ESI) source with a spray voltage of 4
MS:MS_COMMENTS                   	keV in positive mode and 3.5 keV in negative mode were used
MS:ION_MODE                      	POSITIVE and NEGATIVE
MS:MS_RESULTS_FILE               	ST002798_AN004552_Results.txt	UNITS:Peak area	Has m/z:Yes	Has RT:Yes	RT units:Seconds
#END